logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11361841 B1

PDFFull Text
Date of Patent:
Jun. 14, 2022

Filed:

Feb. 10, 2017

High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies

Applicants:

Nantomics, Llc, Culver City, CA (US);

Nant Holdings Ip, Llc, Culver City, CA (US);

Inventors:

Andrew Nguyen, Culver City, CA (US);

John Zachary Sanborn, Culver City, CA (US);

Stephen Charles Benz, Santa Cruz, CA (US);

Kayvan Niazi, Culver City, CA (US);

Shahrooz Rabizadeh, Culver City, CA (US);

Patrick Soon-Shiong, Culver City, CA (US);

Charles Joseph Vaske, Culver City, CA (US);

Assignee:

Nantomics LLC, Culver City, CA (US);

Attorneys:

Martin Fessenmaier

Umberg Zipser LLP

Primary Examiner:

Lori A Clow

Int. Cl.
CPC ...
G16B 20/20 (2019.01); G16B 20/00 (2019.01); A61K 35/17 (2015.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); C12Q 1/6886 (2018.01); A61K 47/68 (2017.01); A61K 39/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
G16B 20/20 (2019.02); A61K 35/17 (2013.01); A61K 39/0011 (2013.01); A61K 39/395 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/6851 (2017.08); A61K 48/00 (2013.01); C12Q 1/6886 (2013.01); G16B 20/00 (2019.02); A61K 39/00 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01);
Abstract

Systems and methods are presented that allow for selection of tumor neoepitopes that are filtered for various criteria. In particularly contemplated aspects, filtering includes a step in which the mutation leading to the neoepitope is ascertained as being located in a cancer driver gene.

Find Patent Forward Citations

Quick Actions:

Nguyen, Andrew. (2022). High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies (U.S. Patent No. 11361841). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11361841

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…